SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-139671
Filing Date
2011-05-13
Accepted
2011-05-13 16:58:08
Documents
12
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 577784
2 DISTRIBUTION AGREEMENT dex101.htm EX-10.1 118443
3 2011 SPECIAL PROGRAMS ADDENDUM TO THE INOVA AGREEMENT dex102.htm EX-10.2 22420
4 FIRST AMENDEMENT TO THE INOVA AGREEMENT dex103.htm EX-10.3 9577
5 ADDENDUM NO. 3 TO THE MASTER SUPPLY AGREEMENT dex104.htm EX-10.4 8006
6 PURCHASE AGREEMENT dex105.htm EX-10.5 27077
7 VOLUME DISCOUNT ADDENDUM TO THE PURCHASE AGREEMENT dex106.htm EX-10.6 13163
8 VOLUME DISCOUNT ADDENDUM NO. 2 TO THE PURCHASE AGREEMENT dex107.htm EX-10.7 12273
9 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 9948
10 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 9975
11 CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 4421
12 CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 4473
  Complete submission text file 0001193125-11-139671.txt   818647
Mailing Address 343 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-246-6400
diaDexus, Inc. (Filer) CIK: 0001036968 (see all company filings)

IRS No.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26483 | Film No.: 11841918
SIC: 2834 Pharmaceutical Preparations